Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nietgen, G. W.
Right arrow Articles by Durieux, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nietgen, G. W.
Right arrow Articles by Durieux, M. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 81, Issue 4 569-577, Copyright © 1998 by The Board of Management and Trustees of the British Journal of Anaesthesia


LABORATORY INVESTIGATIONS

Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetylcholine receptor function

G. W. Nietgen, C. W. Honemann, C. K. Chan, G. L. Kamatchi and M. E. Durieux
Department of Anaesthesiology, University of Virginia Health Sciences Center, PO Box 10010, Charlottesville, VA 22903-0010, USA

Muscarinic acetylcholine signalling plays major roles in regulation of consciousness, cognitive functioning, pain perception and circulatory homeostasis. Halothane has been shown to inhibit m1 muscarinic signalling. However, no comparative data are available for desflurane, sevoflurane or isoflurane, nor have the anaesthetic effects on the m3 subtype (which is also prominent in the brain) been studied. Therefore, we have investigated the effects of these compounds on isolated m1 and m3 muscarinic receptor function. Defolliculated Xenopus oocytes expressing recombinant m1 or m3 muscarinic or (for comparison) AT1A angiotensin II receptors were voltage clamped, and Ca(2+)-activated Cl- currents (ICl(Ca)) induced by acetyl-beta-methylcholine (Mch) or angiotensin II were measured in the presence of clinically relevant concentrations of halothane, sevoflurane, desflurane or isoflurane. To determine the site of action of the volatile anaesthetics we compared anaesthetic effects on m1, m3 and AT1A receptor function and studied the effects of volatile anaesthetics on signalling induced by intracellular injection of the second messenger IP3. Desflurane had a biphasic effect on m1 signalling, enhancing at a concentration of 0.46 mmol litre-1 but depressing at 0.92 mmol litre-1. A similar, although not significant, trend was observed with m3 signalling. Isoflurane had no effect on m1 signalling, but profoundly inhibited m3 signalling. Sevoflurane depressed the function of m1 and m3 signalling in a dose- dependent manner. Halothane, similar to its known effect on m1 signalling, dose-dependently depressed m3 function. ICl(Ca) induced by intracellular injections of IP3 were unaffected by all four anaesthetics. Similarly, none of the anaesthetics tested affected AT1A signalling. Absence of interference with AT1A signalling and intracellular pathways suggest that the effects of anaesthetics on muscarinic signalling most likely result from interactions with the m1 or m3 receptor molecule. Multiple interaction sites with different affinities may explain the biphasic response to desflurane. Anaesthetic- specific effects on closely related receptor subtypes suggest defined sites of action for volatile anaesthetics on the receptor protein.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
O. Murasaki, M. Kaibara, Y. Nagase, S. Mitarai, Y. Doi, K. Sumikawa, and K. Taniyama
Site of Action of the General Anesthetic Propofol in Muscarinic M1 Receptor-Mediated Signal Transduction
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 995 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. W. Hollmann, K. Kurz, S. Herroeder, D. Struemper, K. Hahnenkamp, N. S. Berkelmans, C. G. den Bakker, and M. E. Durieux
The Effects of S(-)-, R(+)-, and Racemic Bupivacaine on Lysophosphatidate-Induced Priming of Human Neutrophils
Anesth. Analg., October 1, 2003; 97(4): 1053 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F.J. Mercier, E. Naline, M. Bardou, O. Georges, A. Denjean, D. Benhamou, and C. Advenier
Relaxation of proximal and distal isolated human bronchi by halothane, isoflurane and desflurane
Eur. Respir. J., August 1, 2002; 20(2): 286 - 292.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Paraskeva, K. Papilas, A. Fassoulaki, A. Melemeni, and G. Papadopoulos
Physostigmine Does Not Antagonize Sevoflurane Anesthesia Assessed by Bispectral Index or Enhances Recovery
Anesth. Analg., March 1, 2002; 94(3): 569 - 572.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S.-H. Do, G. L. Kamatchi, and M. E. Durieux
The Effects of Isoflurane on Native and Chimeric Muscarinic Acetylcholine Receptors: The Role of Protein Kinase C
Anesth. Analg., August 1, 2001; 93(2): 375 - 381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. W. Hollmann, K. S. Wieczorek, A. Berger, and M. E. Durieux
Local Anesthetic Inhibition of G Protein-Coupled Receptor Signaling by Interference with G{alpha}q Protein Function
Mol. Pharmacol., February 1, 2001; 59(2): 294 - 301.
[Abstract] [Full Text]


Home page
Br J AnaesthHome page
L. Pain, H. Jeltsch, O. Lehmann, C. Lazarus, F. Z. Laalou, and J. C. Cassel
Central cholinergic depletion induced by 192 IgG-Saporin alleviates the sedative effects of propofol in rats
Br. J. Anaesth., December 1, 2000; 85(6): 869 - 873.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.